8/19/2019 The Association of Epstein-barr Virus
1/25
THE ASSOCIATION OFTHE ASSOCIATION OFEPSTEIN-BARR VIRUSEPSTEIN-BARR VIRUS
IN NASOPHARENGEALIN NASOPHARENGEALCARCINOMACARCINOMA
DYAH RATNA BUDIANIDYAH RATNA BUDIANI( DEPT OF PATHOLOGY ANATOMY/ BIOMEDICAL( DEPT OF PATHOLOGY ANATOMY/ BIOMEDICAL
LABORATORY SCHOOL OF MEDICINELABORATORY SCHOOL OF MEDICINE
SEBELAS MARET UNIVERSITY)SEBELAS MARET UNIVERSITY)
8/19/2019 The Association of Epstein-barr Virus
2/25
• Pathmanathan et al. (1995) : mela!"#a$ a%a$&a
a'!'a' a$a"a EBV a%a NPC* Hal $ 'a$+a me$a"#
#a"e$a meml# ml#a' e"ae,# 'e"a #la".#a'
e$a$+ %ae"a e$%em#*
• Raab-Traub & Flyn (1986): $0a'0e NPC me$+a$%,$+
e'!me DNA EBV
• Yeung WM, et al. (1993). DNA EBV 'e1a"a '!"a%'
e"%'"2,'#a$ a%a in situ 1a"'$!ma $a'!.a"$+*
E!te"n-#arr $"ru! an% a!'aryngeal an*er
8/19/2019 The Association of Epstein-barr Virus
3/25
EBV $.e1!$EBV $.e1!$ in vivoin vivo
8/19/2019 The Association of Epstein-barr Virus
4/25
8/19/2019 The Association of Epstein-barr Virus
5/25
+*eat"* re!entat"'n ' "n"t"al e$ent! lea%"ng t' E#-"n%u*e%+*eat"* re!entat"'n ' "n"t"al e$ent! lea%"ng t' E#-"n%u*e%
tran!'rat"'n ' /uan #-*ell.tran!'rat"'n ' /uan #-*ell.
8/19/2019 The Association of Epstein-barr Virus
6/25
E# 0EE+E# 0EE+ FT2FT2
E#41 Ma"ntenan*e ' $"ral gen'e "n %"$"%"ng '!t *ell
uregulat"'n ' R40-1 an%-e7re!!"'n
E#4 Fun*t"'nal ''l'g ' 't*: tran!a*t"$at"'n ' E# &*ellular gene! a*t"$ate! *-gr, "n%u*e0-01 tran!"t"'nt'geter "t E#4-;, "n%u*e! M;1 e7re!!"'n e!!ent"al'r #-*ell tran!'rat"'n
E#43a
8/19/2019 The Association of Epstein-barr Virus
7/25
E#E#0EE+0EE+
FT2FT2
#/RF1 Fun*t"'naly an% !tru*turally ''l'g'u! t' b*l:"n"b"t a't'!"! %"!trub! %"erent"at"'n & "n%u*e!r'l"erat"'n "n e"tel"al *ell!
E#ER1
8/19/2019 The Association of Epstein-barr Virus
8/25
+*eat"* rere!entat"'n ' E# R4 e7re!!"'n r'"le! "n %"erent E#-
"ne*te% #-*ell 'ulat"'n! "n t'n!"l! an% er"eral bl''%
' ealty E#-*arr"er! an% te"r r''!e% relat"'n!"
8/19/2019 The Association of Epstein-barr Virus
9/25
+*eat"* rere!entat"'n ' E# R4 e7re!!"'n r'"le! "n %"erent
E#-"ne*te% #-*ell 'ulat"'n! "n t'n!"l! an% er"eral bl''% '
ealty E#-*arr"er! an% te"r r''!e% relat"'n!"*
a"$e #-*ell! are "ne*te% by E#-$"r"'n! tat enter te 'r'aryngeal
ly n'%e! by *r'!!"ng e"tel"al barr"er!. E# gly*'r't*"n g35
b"n%! t' te re*et'r A1 re!ent 'n all #-*ell!. n%er "nluen*e '
A1-tr"gger"ng an% te !ub!eBuent E#4-%r"$en tran!*r"t"'n
r'gra, na"$e #-*ell! %"erent"atC "nt' # bla!t! tat e7re!! te ull
!et ' latent E# R4! an% "* are r'bably *'ntr'lle% by ant"-E#
*yt't'7"* T-*ell re!'n!e!. Te # bla!t urter %"erent"ate! tr'ug
te ger"nal *enter $"a *entr'bla!t t' *entr'*yte. #'t *ell tye!
e7re!! te latent ebrane r'te"n! M;1 an% M;, "* r'$"%e!
te "t gr't an% !ur$"$al !"gnal! "n ab!en*e ' ant"gen, an%E#42 "* "! e!!ent"al 'r a"ntenan*e ' te $"ral gen'e "n te
'!t *ell. F"nally, %"erent"ate% E#-"ne*te% *ell, enter te *"r*ulat"'n
"t! e'ry #-*ell!, tat are generally !"lent 'r $"ral R4 e7re!!"'n
but :ay '**a!"'nally e7re!! M; R4 (Ar +. +te$en! "!
a*=n'le%ge% 'r r'$"%"ng t"! "gure).
8/19/2019 The Association of Epstein-barr Virus
10/25
;at'gen"* ee*t!;at'gen"* ee*t! E# gene r'%u*t re!'n!"bleE# gene r'%u*t re!'n!"ble
Inhibition of apoptosis
M""*="ng #*l- un*t"'n
regulat"'n ' #*l-regulat"'n ' 4
Genetic instability
;a!!"$e "n%u*t"'n ' tran!lat"'n.
4*t"$e "n%u*t"'n ' tran!l'*at"'n $"a R40-1
8/19/2019 The Association of Epstein-barr Virus
11/25
ter E# gene!
E# 0EE+E# 0EE+ FT2FT2
#+MF1 4T24TE+ 0EE ED;RE++2 ;+T-TR4+R2;T24Y
E4-A(#MRF1) 4T24TEA #Y ?ta a!!'*"te! "t E# A4 ;'lyera!e
#4F5 A4 ;YMER4+E
#4F M4R A4 #2A20 ;RTE2
#DF1 T/YM2A2E >24+E
#F1 0;35;RTE2
#0F5 4>42E EDE4+E
8/19/2019 The Association of Epstein-barr Virus
12/25
• 3e'e"$ 1!,$"e' (a$$,al $1%e$1e : 4*51a'e'/ 644*4444*
• S!, a'a/ N!" A."1a G"ee$la$% a$%
Ala'#a m!"e a$ 75 /644*444
EBV $ NPCEBV $ NPC
8/19/2019 The Association of Epstein-barr Virus
13/25
EBV $ NPCEBV $ NPC
• Te a!!'*"at"'n ' E# 'n =erat"n"!"ng*ar*"n'a (W/ 22) an% art"*ularyun%"$erent"ate% !ub tye(W/ t"e 222) "! elle!tabl"!e%.
• +all r''rt"'n ' +Bua'u! *ar*"n'a(W/ t"e 2) : u!"ng ;R %ete*t"'n $"ralA4.
• +Bua'u! *ell! ; "! aear! t' !'
ge'gra"*al $ar"ab"l"ty.• Re*ent !tu%y : +''="ng an% 'r "ne*t"'n
/;! "gt be "n$'l$e% "n at'gene!"! '!Bua'u! *ell! ;.
8/19/2019 The Association of Epstein-barr Virus
14/25
• augan et al : !'="ng a! a r"!= a*t'r 'r!!* ;! but n't 'r n'n-=erat"na!"n"ng*ar*"n'a.!"ng ;R(/'r%"ng et al ) %ete*te% /; A4
"n !'e ++ tat er E# negat"$e.• Ra!e= et al : 'un% E# an% /; A4 by
;R "n 88 an% 53 ' ;( all /; '!"t"$e*a!e! ere al!' E# '!"t"$e )
• Ten%en*y : /; G un%"eren*"ate%*ar*"n'a an% /; - ++ ;!
8/19/2019 The Association of Epstein-barr Virus
15/25
ED;RE++2 F E#4! & M;! #ED;RE++2 F E#4! & M;! #
ly'a!ly'a! r'$"%e! "n%"*at"'n! ' b"'*e"*al!r'$"%e! "n%"*at"'n! ' b"'*e"*al!
e*an"!! : "n r"ary # y'*yte gr't.e*an"!! : "n r"ary # y'*yte gr't.
e7re!! 'n an 'r un* 'n ! ' u a e y
8/19/2019 The Association of Epstein-barr Virus
16/25
e7re!! 'n an 'r un* 'n ! ' u a e y
0ene Fun*t"'n Relat"'n "t E#
2n $"tr';53 T,m!" ',"e''!"
+e$e 8*ell *y*le *e*='"ntH
B1l-7 I$2' a!!''
A74 I$2' a!!''
1-.+" P"!e$ &"!'$e #$a'e1-m&1 Cell P"!l.e"a!$
R2 T,m!" ',"e''!"
+e$e9 B$%$+ ! E7F
"e0e$' e$"& ! S
a'e*IL-64 B-Cell "!l.e"a!$9
$2!$ !. l!1al
mm,$e "e'!$'e
P"!e$ 2!,$% 2& EBNA-LP
U"e+,lae% 2& LMP6
U"e+,lae% 2& LMP6
U"e+,lae% 2& EBNA7U"e+,lae% ,!$ EBV $.e1!$*
B!,$% 2& EBNA-LP
U"e+,lae% ,!$ EBV $.e1!$*
8/19/2019 The Association of Epstein-barr Virus
17/25
0ene Fun*t"'n Relat"'n "t E# in vivo
;53
#*l-
4
*-gr
*-y*
Rb
IL-64
T,m!" ',"e''!"
+e$e 8*ell *y*le *e*='"ntH
I$2' a!!''
I$2' a!!''
P"!e$ &"!'$e #$a'e
Cell P"!l.e"a!$
T,m!" ',"e''!"
+e$e9 B$%$+ ! E7F
"e0e$' e$"& ! S
a'e*
B-Cell "!l.e"a!$9
$2!$ !. l!1al
mm,$e "e'!$'e
I$ HD : $!$e
U"e+,lae% $ PLTD
I$ HD : $!$e
I$ HD : $!$e9 U"e+,lae% $ PLTD ARL*
I$ HD : $!$e
U$#$!$
U"e+,lae% $ EBV ;HD
'ne : n' %"ern*e! 'un% 'r E#G an% E#- *a!e!
8/19/2019 The Association of Epstein-barr Virus
18/25
8/19/2019 The Association of Epstein-barr Virus
19/25
8/19/2019 The Association of Epstein-barr Virus
20/25
8/19/2019 The Association of Epstein-barr Virus
21/25
EBVEBVmal+$a$'
8/19/2019 The Association of Epstein-barr Virus
22/25
8/19/2019 The Association of Epstein-barr Virus
23/25
A!!'' a$% "!l.e"a!$ 1!$"!l A!!'' a$% "!l.e"a!$ 1!$"!l
M;1M;1
4;;T+2+
8/19/2019 The Association of Epstein-barr Virus
24/25
4;;T+2+
S+$al$+ aa& .!" TNFR-1 (55 #Da) a$% TNFR-2 (=5 #Da) !11,"' 2& e
"e1",me$ !. 'e0e"al a%ae" "!e$' ! e $"a1ell,la" "e1e!" 1!mle>* Omal
'+$al$+ a10& "e?,"e' "e1e!" "me"@a!$* TNFR-6 $all& "e1",' TRADD
(TNFRa''!1ae% %ea %!ma$) a$% $%,1e' a!!'' "!,+ e a1!$' !.
"!e!l&1 e$@&me' #$!$ a' 1a'a'e' a aa& 'a"e% 2& a$!e" "e1e!"#$!$ a' CD5 (Fa')* CD5 a$% TNFRI !''e'' 'mla" $"a1ell,la" 'e?,e$1e'
#$!$ a' %ea %!ma$' (DD) a$% 2! "e1", e 'ame a%ae" "!e$' #$!$ a'
Fa'-a''!1ae% %ea %!ma$ (FADD) 2e.!"e a10a$+ 1a'a'e-* TNFR-6 al'!
$%,1e' a!!'' 2& a10a$+ 1a'a'e-7 "!,+ e "e1",me$ !. RIP ("e1e!"
$e"a1$+ "!e$)* RIP al'! a' a .,$1!$al 1!m!$e$ a 1a$ $ae NF-B a$%
1-,$ a10a!$ 2! .a0!"$+ 1ell ',"00al a"*C "!$.lamma!"& .,$1!$'* TNFR-7
la1#' a DD 1!m!$e$ 2, "e1",' a%ae" "!e$' #$!$ a' TRAFI a$% TRAF2
(TNFR-a''!1ae% .a1!") a $e"a1 RIP ! me%ae NF-B a$% 1-,$ a1
0a!$* TRAF7 al'! "e1",' a%%!$al "!e$' a a"e a$a!!1 #$!$ a' IAP
($2!"' !. a!!'' "!e$l* DED, %ea e..e1!" %!ma$9 RAIDD, RIP-a''!1ae%
ICH-6-l#e "!e$ %ea %!ma$ 1 a10ae' "!a!!1 1a'a'e'9 MEKKl,m!+e$-a10ae% "!e$/E"l1 #$a'e #$a'e-69 INK, 1-,$ N-e"m$al #$a'e9 NIK, NF-
B-$%,1$+ #$a'e9 6->B/NF-B $a10e 1!mle> !. NFB a 2e1!me' a10ae%
e$ I-B !"!$ ' 1lea0e%* (A%ae% ."!m L$ e al*& e"m''!$*)
8/19/2019 The Association of Epstein-barr Virus
25/25
Top Related